Big pharma’s 40-year love affair with outsourcing everything must end
otherwise investors will take their money elsewhere
[This is the thinking behind an interview with Megan Redshaw for TrialSite News yesterday evening, out next week]
Hypothesis for the interview
Big pharma’s 40-year love affair with outsourcing everything must end, otherwise investors will take their money elsewhere.
Why—three main reasons
Pharma manufacturers divested their physical storage, logistics and d…